(Reuters) -Hims & Hers Health has appointed Deb Autor as its first chief policy officer to lead public policy and government functions, the telehealth firm said on Monday.
Autor brings more than three decades of experience, having served as the deputy commissioner for global regulatory operations and policy at the U.S. Food and Drug Administration as well as having held a senior role in AstraZeneca.
She has been a member of the Hims & Hers’ board since last year, and will continue in that role.
Autor’s appointment comes as Hims & Hers scales its engagement with regulators and policymakers, it said.
In September, Hims came under the FDA’s scrutiny for what the agency called misleading marketing.
Hims has also shifted to selling “personalized” versions of semaglutide, the active ingredient in Novo Nordisk’s weight-loss drug Wegovy, following the government’s ban on the mass production of copies.
In the new role, Autor will collaborate with consumers, telehealth platforms, providers, pharmaceutical companies, policymakers, and regulators, Hims said.
(Reporting by Sneha S K in Bengaluru; Editing by Sahal Muhammed)
Brought to you by www.srnnews.com
